Senescence-like induction through the p27 pathway may be a consequence of defects in the p53 and p16 pro-senescence pathways in GBM and could be exploited to overcome the PTEN loss in this tumor [11,32]. The gene discussed is CDKN2A; the disease is glioblastoma.